Memo inOncology SPECIAL ISSUE congress report WCLC 2020 is now available!
The latest memo inOncology SPECIAL ISSUE summarizes a selection of abstracts of clinical interest ranging from early-stage disease to the metastatic setting. This report brings the role of adjuvant chemotherapy as well as targeted options and sequencing issues with KRAS, HER2 and ALK mutations into focus. Moreover, novel treatment approaches in the EGFR-mutated NSCLC and small-cell lung cancer, relapsed malignant mesothelioma or pretreated NSCLC are among other topics reviewed. As an additional feature, you will find expert video interviews with Alex Spira, Luis M. Montuenga & Ming Tsao on different conference highlights on our website. Another video interview with Sandip Patel will be released beginning of April. Download full report The memo inOncology Special Issue report is produced by Springer, as a supplement of memo (the Magazine of European Medical Oncology) and sponsored by Boehringer Ingelheim and BeiGene with an unrestricted educational grant. For more information on the memo inOncology Special Issue series, and for free access to all previous editions, visit the memo-inOncology website.
Ragma 21 – 14° GEICAM Annual Review of Advances in Breast Cancer
In this annual multidisciplinary meeting, attended by all professionals related to breast cancer, a comprehensive review of the advances in research, diagnosis and treatment of this disease is carried out.The main objective of this event is to become the reference for all those interested in knowing in an independent, complete and critical way the advances in breast cancer. The event will take place on June 17th and 18th in a virtual format. Sign up on the website:: https://www.ragmageicam.org/ Check out the event schedule
ASCO Direct™ Webinar: 2021 LATAM Highlights
Live Webinar, Saturday July 3th The program will offer a scientific update including original presentations from the 2021 ASCO® Annual Meeting. Renowned international speakers will select the most significant studies and provide insights on how the results may impact on clinical practice. Relevant regional speakers will complement the presentations by demonstrating the impact on clinical practice with updates to current treatment algorithms. Each section will feature a rich clinical discussion moderated by the Program chair and co-chair, complemented by opportunities for questions to be raised by the participating audience. This program has been made possible through Platinum sponsorship from MSD and Silver sponsorship from BIOMM. Register to participate
Sequential therapies for advanced urothelial cancer: Hope meets new challenges
Daniel Herchenhorn, Vinicius Freire, Thamires Oliveira, Juliana Tarouquella - Crit Rev Oncol Hematol. 2021 April
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial
Sibylle Loibl, Frederik Marmé, Miguel Martin, Michael Untch, Hervé Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole McCarthy, Mireia Melé Olivé, Karen Gelmon, José García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Carsten Denkert, Michael Gnant, Andreas Makris, Maria Koehler, Cynthia Huang-Bartelett, Maria Jose Lechuga Frean, Marco Colleoni, Gustavo Werutsky, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Gunter von Minckwitz - Journal of Clinical Oncology. April 01, 2021.
Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies
Carlos Barrios, Ruffo Freitas-Junior, Sandro Martins, Jose Bines, Maria Del Pilar Estevez-Diz, Maira Caleffi - Journal of Clinical Oncology no. 7. April 6, 2021
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L Mayer, Amylou C Dueck, Miguel Martin, Gabor Rubovszky, Harold J Burstein, Meritxell Bellet-Ezquerra, Kathy D Miller, Nicholas Zdenkowski, Eric P Winer, Georg Pfeiler, Matthew Goetz, Manuel Ruiz-Borrego, Daniel Anderson Zbigniew Nowecki, Sibylle Loibl, Stacy Moulder, Alistair Ring, Florian Fitzal, Tiffany Traina, Arlene Chan, Hope S Rugo, Julie Lemieux, Fernando Henao, Alan Lyss, Silvia Antolin Novoa, Antonio C Wolff, Marcus Vetter, Daniel Egle, Patrick G Morris, Eleftherios P Mamounas, Miguel J Gil-Gil, Aleix Prat, Hannes Fohler, Otto Metzger Filho, Magdalena Schwarz, Carter Du Frane, Debora Fumagalli, Kathy Puyana Theall, Dongrui Ray, Cynthia Huang, Maria Koehler, Christian Fesl, Angela De Michele, Michael Gnant - The Lancet Oncology. Volume 22, Issue 2, February 2021
Comprehensive genomic profiling of Brazilian non‐small cell lung cancer patients (GBOT 0118/LACOG0418)
Eldsamira Mascarenhas, Ana Caroline Gelatti, Luiz Henrique Araújo, Clarissa Baldotto, Clarissa Mathias, Mauro Zukin, Gustavo Werutsky, Patricia Pacheco, Rafaela Gomes, Gilberto de Castro Jr, Vladmir Cláudio Cordeiro de Lima - Thoracic Cancer, 13 December 2020
Save the Date – Best of ASCO 2021
LACOG and Instituto Ética will promote the event officially licensed by ASCO, the Best of ASCO Annual Meeting. This year the scientific program will be broadcast online, from June 14th to 16th, 2021. Save the date and participate! Sign up here